Concepedia

Jennie H. Best

JH

Statistics

Publications

22

Citations

1.1K

H-Index

18

Active since

1997

Affiliations

University of Washington(Current)

Eli Lilly (United States)

Bristol-Myers Squibb (United States)

Johns Hopkins University

QIMR Berghofer Medical Research Institute

Jennie H. Best is an author at University of Washington specializing in pharmacotherapy, diabetes mellitus, and clinical pharmacology.

Publications per year

1997–2021

22

Publications

22

Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies

Jennie H. Best, Byron J. Hoogwerf, William H. Herman et al. · Diabetes Care · 2010 · 252 citations · Full text

, , +17

Patient perspectives on once‐weekly medications for diabetes

William H. Polonsky, Lawrence Fisher, Danielle Hessler et al. · Diabetes Obesity and Metabolism · 2010 · 128 citations

, , +16

Improved treatment satisfaction and weight‐related quality of life with exenatide once weekly or twice daily<sup>1</sup>

Jennie H. Best, Kristina S. Boye, R. R. Rubin et al. · Diabetic Medicine · 2009 · 97 citations · Full text

, , +16

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B‐cell lymphoma

John Hornberger, Jennie H. Best · Cancer · 2005 · 60 citations · Full text

, , +14

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

Sebastian Unizony, Timothy J. McCulley, Robert Spiera et al. · Arthritis Research & Therapy · 2021 · 60 citations · Full text

, , +13

1–5 of 22